Richard Roden

21PUBLICATIONS
70CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsPredictive and prognostic markersCharacterisation of biological macromoleculesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jan 15, 2025
MmuPV1 infection of Tmc6/Ever1 or Tmc8/Ever2 deficient FVB mice as a model of βHPV in typical epidermodysplasia verruciformis.

Margaret Wong, Hsin-Fang Tu, Ssu-Hsieh Tseng

|Jul 11, 2024
Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancer.

Ravi K Anchoori, Ssu-Hsueh Tseng, Hua-Ling Tsai

|Jun 27, 2024
Vaccination with a Human Papillomavirus L2 Multimer Provides Broad Protection against 17 Human Papillomavirus Types in the Mouse Cervicovaginal Challenge Model.

Zhenwei Han, Shen Wang, Ting Mu

|Jun 29, 2023
Mus musculus papillomavirus 1 E8^E2 represses expression of late protein E4 in basal-like keratinocytes via NCoR/SMRT-HDAC3 co-repressor complexes to enable wart formation <i>in vivo</i>.

Franziska Kuehner, Margaret Wong, Elke Straub

|Jun 14, 2023
Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor.

Ravi K Anchoori, Vidyasagar Anchoori, Brandon Lam

|Jan 06, 2023
Safety Run-in of Intramuscular pNGVL4a-Sig/E7(detox)/HSP70 DNA and TA-CIN Protein Vaccination as Treatment for HPV16+ ASC-US, ASC-H, or LSIL/CIN1.

Mark H Einstein, Richard B S Roden, Louise Ferrall

Pageof 4

Frequent Collaborators

2 joint publications

Samarjit Das

2 joint publications

T-C Wu

2 joint publications

Chien-Fu Hung

2 joint publications

Frank Stubenrauch